Scorpius Holdings Faces Delisting Concerns
Ticker: SCPX · Form: 8-K · Filed: Jul 30, 2024 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0002 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: SCPX
TL;DR
SCPX might get kicked off the exchange - big trouble.
AI Summary
Scorpius Holdings, Inc. filed an 8-K on July 30, 2024, reporting a notice of delisting or failure to meet continued listing standards. The company, formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC., is based in Morrisville, NC.
Why It Matters
This filing indicates potential issues with Scorpius Holdings' ability to remain listed on its exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation and stock viability.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- NightHawk Biosciences, Inc. (company) — Former Company Name
- HEAT BIOLOGICS, INC. (company) — Former Company Name
- July 29, 2024 (date) — Earliest event reported
- July 30, 2024 (date) — Filing Date
FAQ
What is the specific reason for Scorpius Holdings, Inc.'s potential delisting?
The filing indicates a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard not met in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 29, 2024.
What is Scorpius Holdings, Inc.'s business address?
The business address is 627 Davis Drive, Suite 300, Morrisville, NC 27560.
What were the previous names of Scorpius Holdings, Inc.?
The company was formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.
What is the SIC code for Scorpius Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 630 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-07-30 08:05:08
Key Financial Figures
- $0.0002 — nge on which registered Common Stock, $0.0002 par value per share SCPX NYSE America
Filing Documents
- scpx_8k.htm (8-K) — 32KB
- ex99x1.htm (EX-99.1) — 5KB
- 0001079973-24-001121.txt ( ) — 251KB
- scpx-20240729.xsd (EX-101.SCH) — 3KB
- scpx-20240729_def.xml (EX-101.DEF) — 26KB
- scpx-20240729_lab.xml (EX-101.LAB) — 36KB
- scpx-20240729_pre.xml (EX-101.PRE) — 25KB
- scpx_8k_htm.xml (XML) — 5KB
01 Notice of
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 29, 2024, the NYSE American LLC (the "Exchange") notified Scorpius Holdings, Inc. (the "Company") that the Exchange has withdrawn its delisting determination and will be lifting the trading suspension of the Company's common stock on the NYSE American. The NYSE Regulation staff determined that the Company's common stock was now trading above the threshold of low selling price issues as further defined by Section 1003(f)(v) of the NYSE American Company Guide. The Company's common stock is expected to resume trading on the NYSE American on Friday, August 2, 2024, under the symbol "SCPX."
01. Other Events
Item 7.01. Other Events. On July 30, 2024, the Company issued a press release relating to the lifting of the trading suspension of the Company's common stock on the NYSE American described in this Current Report on Form 8-K. A copy of the press release attached as Exhibit 99.1 to this report is being furnished and incorporated by reference into this Item 7.01 and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this Item 7.01 and the accompanying exhibit shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Press Release date July 30, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: July 30, 2024 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer